Pharmacotherapy in COVID 19: Potential Impact of Targeting the Complement System

Coronavirus disease 2019 (COVID-19), a respiratory illness caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has claimed over one million lives worldwide since December 2019. The complement system, while a first-line immune defense against invading pathogens, has...

Descripción completa

Detalles Bibliográficos
Autores principales: Barkoff, Courtney M., Mousa, Shaker A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823480/
https://www.ncbi.nlm.nih.gov/pubmed/33374356
http://dx.doi.org/10.3390/biomedicines9010011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823480/
https://www.ncbi.nlm.nih.gov/pubmed/33374356
http://dx.doi.org/10.3390/biomedicines9010011

Ejemplares similares